About US
Contact us
-
Celgene off-label marketing lawsuit documents unsealedCelgene ($CELG) has successfully fought off several lawsuits suggesting the success of its blockbuster multiple myeloma meds Revlimid and Thalomid relied on aggressive off-label marketing.A California2016/10/8
-
GSK to sell remaining stake in South African drugmaker AspenGlaxoSmithKline (GSK) is planning to divest its remaining stake in South African drugmaker Aspen Pharmacare. The company plans to sell up to 28.2 million ordinary shares in Aspen for a price that wil2016/9/30
-
Kenya launches world's first child-friendly TB medicinesKenya has launched the world's first drug specifically designed to treat tuberculosis (TB) in children. The launch follows a recent pre-qualification by the World Health Organisation to use improved2016/9/30
-
AssistRx and NewCrop to improve capabilities for electronic health recordsUS-based provider of web based pharmaceutical data management solutions AssistRxhas collaborated with local e-prescribing service firm NewCrop to improve capabilities for electronic health records (EH2016/9/29
-
EMA and FDA establish new cluster to support medicine development for rare diseasesThe European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) have established a new cluster to boost the development of medicines for rare diseases. The new cluster wi2016/9/29
-
Parexel enters definitive agreement to acquire ExecuPharmUS-based Parexel, one of the world's biggest contract research organisations, has entered a definitive agreement to purchase ExecuPharm for an undisclosed amount. Headquartered in US and established2016/9/28
-
Pharmaron to acquire Merck Sharpe & Dohme's Hoddesdon research facility in UKPharmaron has signed a non-binding heads of terms with Merck Sharpe & Dohme Limited (MSD) for the purchase of UK-based Hoddesdon site, which comprises MSD’s process development and research facili2016/9/28
-
Allele receives NIH grant to develop new antibody therapy for Alzheimer’s diseaseAllele Biotechnology and Pharmaceuticals (Allele) has secured a grant from the US National Institutes of Health's (NIH) National Institute on Aging to develop a new antibody therapy for Alzheimer’s di2016/9/27
-
US FDA accepts Sanofi and Regeneron’s dupilumab BLA for priority reviewThe US Food and Drug Administration (FDA) has granted priority review status to Sanofi and Regeneron’s biologics license application (BLA) for dupilumab to treat adult patients with inadequately contr2016/9/27
-
US FDA grants approval for Novartis' Ilaris to treat Periodic Fever SyndromesNovartis has received the US Food and Drug Administration's (FDA) approval for Ilaris (canakinumab) to treat rare Periodic Fever Syndrome conditions. Periodic Fever Syndromes are a group of diseases2016/9/26